Stephanie Gort, PA
Physician Assistant · West Hartford, CTNPI 1043610462
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Novo Nordisk accounts for 63.3% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $15,864, more than ten times the $124 reported in 2021. Among physician assistant clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 219 payments — averaging $86.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$12K
- Madrigal Pharmaceuticals$3K
- AbbVie$898
- Ardelyx, Inc.$607
- Takeda Pharmaceuticals U.S.A., Inc.$498
- Lilly USA, LLC$416
- plus $2K from 20 others
What the payments were for
- Consulting fees$1,2156%
- Speaking & faculty fees$10,41555%
- Travel & lodging$1,3497%
- Food & beverage$5,87031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 23 | $11,922 |
| Madrigal Pharmaceuticals | 21 | $2,582 |
| AbbVie | 45 | $898 |
| Ardelyx, Inc. | 27 | $607 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $498 |
| Lilly USA, LLC | 17 | $416 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $280 |
| Gilead | 5 | $234 |
| Phathom Pharmaceuticals, Inc. | 5 | $206 |
| Ironwood Pharmaceuticals, Inc | 7 | $165 |
| Bristol Myers Squibb | 3 | $157 |
| Medtronic | 1 | $124 |
| E.r. Squibb & Sons, L.L.C. | 1 | $123 |
| Pfizer | 5 | $100 |
| Celltrion USA Inc. | 4 | $92 |
| Johnson & Johnson | 4 | $80 |
| Nestle Healthcare Nutrition Inc. | 4 | $72 |
| QOL Medical, LLC | 2 | $66 |
| Intercept Pharmaceuticals, Inc. | 3 | $62 |
| Braintree Laboratories, Inc. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Fresenius Kabi USA, LLC | 1 | $23 |
| Exact Sciences | 1 | $23 |
| Sanofi | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,849 in reported general payments places this provider in the 95th percentile of 1,795 physician assistant providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 41 | $54,796 |
| LinzessLinaclotide | 29 | $39,041 |
| OzempicSemaglutide | 32 | $38,995 |
| Mesalamine | 18 | $9,676 |
| Dexlansoprazole DrDexlansoprazole | 21 | $6,573 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 66 | $3,902 |
| Pantoprazole Sodium | 197 | $2,594 |
| Omeprazole | 147 | $2,579 |
| Famotidine | 113 | $2,252 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 11 | $1,798 |
| Sucralfate | 17 | $1,305 |
| Esomeprazole Magnesium | 38 | $1,134 |
| Lansoprazole | 40 | $1,057 |
| Colestipol Hcl | 11 | $768 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 33 | $618 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $416 | $54,79641 claims |
| AbbVieLinzess | $898 | $39,04129 claims |
| Novo NordiskOzempic | $11,922 | $38,99532 claims |
| Braintree Laboratories, Inc.Sutab | $38 | $1,79811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,795 physician assistant providers in Connecticut.
Other physician assistant in West Hartford
- Kaitlyn ZugibeWest Hartford$16K
- Gary SpinnerBridgeport$119K
- Jordan MarcouTrumbull$44K
- Mary ElliottGuilford$43K
- Christopher ThompsonGroton$42K
- Michael LalondeNew Haven$35K
- Kristine LaneMiddletown$30K
- Kathryn MidgleyNew Haven$28K
- Richard MoroPlainfield$25K
- Janine TedescoDarien$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.